← All organizations

Intarcia Therapeutics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 3, 2017

Timeline

1990s

Jun 1, 1997
Intarcia Therapeutics— Founded

2010s

Sep 24, 2015
Phoundry Pharmaceuticals— Acquired

Drugs by trial phase (18 distinct, 20 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Phoundry Pharmaceuticals

Recent trials (22)

NCT03060980Lead sponsorPhase 3Mar 3, 2017
NCT02650479Lead sponsorPhase 1Jan 1, 2016
NCT02641990Lead sponsorPhase 1Dec 1, 2015
NCT02638805Lead sponsorPhase 3Dec 1, 2015
NCT02641899Lead sponsorPhase 1Dec 1, 2015
NCT02320045Lead sponsorPhase 1Nov 1, 2014
NCT01455870Lead sponsorPhase 3May 1, 2013
NCT01785771Lead sponsorPhase 3May 1, 2013
NCT01455857Lead sponsorPhase 3Mar 1, 2013
NCT01455896Lead sponsorPhase 3Mar 1, 2013
NCT01455922Lead sponsorPhase 3Feb 1, 2013
NCT01455909Lead sponsorPhase 3Feb 1, 2013
NCT01455883Lead sponsorPhase 3Feb 1, 2013
NCT00943917Lead sponsorPhase 2Aug 1, 2009
NCT01798264Lead sponsorPhase 1Feb 1, 2009

Details

Founded: Hayward, CA, US Jun 1, 1997
Last known activity: Mar 3, 2017